In a patient maintained on Suboxone (buprenorphine/naloxone) who has a fracture with worsening pain, can JOURNAVX (suzetrigine) be used for analgesia?

Can JOURNAVX Be Used in Patients on Suboxone with Fracture Pain?

Yes, JOURNAVX (suzetrigine) can be safely used in patients maintained on Suboxone who have fracture-related pain, as it works through a completely different mechanism (selective NaV1.8 sodium channel inhibition) that does not interact with opioid receptors.

Mechanism and Rationale

JOURNAVX represents a fundamentally different approach to pain management that bypasses the complex opioid receptor dynamics that complicate acute pain treatment in patients on buprenorphine maintenance therapy 1, 2, 3. Unlike traditional opioid analgesics that must compete with buprenorphine's high affinity for μ-receptors, suzetrigine blocks NaV1.8 sodium channels exclusively expressed on peripheral nociceptors, interrupting pain signals before they reach the central nervous system 2, 3, 4.

This peripheral mechanism offers a critical advantage: it eliminates the pharmacologic competition and receptor displacement concerns that plague opioid-based acute pain management in patients on Suboxone 5.

Clinical Application

Dosing Strategy

• Loading dose: 100 mg orally on an empty stomach (at least 1 hour before or 2 hours after food)
• Maintenance: 50 mg every 12 hours, with or without food
• Duration: Continue for shortest time needed, up to 14 days 1
• Continue Suboxone: Maintain the patient's regular buprenorphine/naloxone regimen unchanged

Assessment Timeline

Evaluate pain relief within 2-4 hours of the loading dose 2. If analgesia is inadequate, supplement with multimodal therapy including NSAIDs and acetaminophen. In clinical trials, 83-91% of patients with diverse surgical and non-surgical acute pain conditions rated pain control as good to excellent 2, 6.

Critical Drug Interactions

Before prescribing, assess for CYP3A inhibitors or inducers:

• Contraindicated: Strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin, ritonavir) 1
• Dose reduction required: Moderate CYP3A inhibitors - reduce to 50 mg loading dose, then 25 mg every 12 hours 1
• Avoid: Strong or moderate CYP3A inducers (will reduce efficacy) 1
• No grapefruit: Avoid grapefruit-containing foods/drinks during treatment 1

Advantages Over Traditional Approaches

The established guidelines for managing acute pain in patients on buprenorphine are complex and problematic 5:

1. Continuing buprenorphine + adding full opioid agonists requires higher opioid doses to compete at receptors, increasing sedation/respiratory depression risk
2. Dividing buprenorphine doses (every 6-8 hours) may provide inadequate analgesia in opioid-tolerant patients
3. Discontinuing buprenorphine risks precipitating withdrawal and destabilizing opioid use disorder, significantly increasing relapse risk 7
4. Converting to methadone is complex and typically only feasible in hospitalized patients 5

JOURNAVX sidesteps all these complications entirely because it doesn't act on opioid receptors 2, 3, 4.

Safety Profile

In clinical trials, suzetrigine demonstrated:

• No abuse or addiction potential 3, 4
• No respiratory depression 3
• No CNS effects typical of opioids 4
• Common side effects: itching (2.1%), muscle spasms (1.3%), elevated CPK (1.1%), rash (1.1%) 1
• Much lower nausea/vomiting rates than opioids (9-20% vs 16-33% with hydrocodone/acetaminophen) 1

Important Caveats

1. Hepatic impairment: Use caution and potentially adjust dosing in patients with liver disease 1
2. Prior authorization: May be required by insurance; address before discharge 2
3. Oral administration only: Patient must be able to swallow tablets whole 1
4. Not a complete opioid replacement: For severe fracture pain, may need to be part of multimodal therapy 2, 6
5. Monitor CPK and renal function: Small percentage show transient CPK elevations or eGFR decreases that resolve after discontinuation 1

Multimodal Strategy

Optimal approach for fracture pain in a patient on Suboxone:

• Continue Suboxone at maintenance dose
• Start JOURNAVX (100 mg loading, then 50 mg q12h)
• Add acetaminophen 650 mg + ibuprofen 400 mg every 6 hours as needed 6
• Reserve opioid rescue only if absolutely necessary (recognizing higher doses may be needed due to buprenorphine's receptor occupancy) 5

This strategy maintains addiction treatment stability while providing effective analgesia through complementary non-opioid mechanisms 7, 6.